Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoLAB: Monthly Depot Buprenorphine for Opioid Dependence
NCT03809143Phase 3Unknown
- Sponsor
- University of New South Wales
- Start
- May 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by University of New South Wales. Status: unknown.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03809143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809143.